Close
Find your Coloplast country website

Key figures

Download key figures (Excel)

DKK million 2015/16  2014/15 2013/14
2012/13
2011/12
           
Income statement          
Revenue 14,681  13,909 12,428
11,635
11,023
Research and development costs -509  -442 -390
-380
-342
Operating profit before interest, tax, depreciation and amortisation 4,624  2,020 3,573
4,160
3,756
Operating profit (EBIT) before special items 4,846  4,535 4,147
3,672
3,255

Special items1)

-750  -3,000 -1,000 0 0
Operating profit (EBIT) 4,096  1,535 3,147
3,672
3,255
Net financial income and expenses -13  -289 46
-46
-300
Profit before tax 4,082  1,245 3,191
3,625
2,954
Net profit for the year 3,143  899 2,390
2,711
2,194
           
Revenue growth          
Annual growth in revenue, % 12 7
6
8
Growth breakdown:          
Organic growth, % 7 9
7
6
Currency effect, % -1  5 -2
-1
2
           
Balance sheet          
Total assets 11,007  10,817 10,379
9,564
10,176
Capital invested 5,551  4,702 6,088
6,320
6,295
Equity at year end 5,068  4,706 6,283
6,769
6,042
           
Cash flows and investments          
Cash flows from operating activities 3,028  3,337 3,149
3,136
2,649
Cash flows from investing activities -603  -468 -777
-159
-390
Investment in property, plant and equipment, gross -627  -583 -505
-409
-317
Free cash flow 2,425  2,869 2,372
2,977
2,259
Cash flows from financing activities -2,868  -2,963 -2,898
-3,430
-1,653
           
Key ratios          
Average number of employees, FTEs 9,817  9,303 8,741
8,143
7,624
Operating margin, EBIT, % 28  11 25
32
30
Operating margin before special items, EBIT before special items, % 33  33 33 32 30
Operating margin, EBITDA, % 31  15 29
36
34
Return on average invested capital before tax (ROIC), %2) 63  62 60
58
52

Return on average invested capital after tax (ROIC), %2)


49  48 49
44
38
Return on equity, % 69  16 37
42
42
Equity ratio, % 46  44 61
71
59
Net asset value per outstanding share, DKK4) 24  22 30 32
29
           
Share data          
Share price, DKK4) 514  473 494
314
242
Share price/net asset value per share4) 21  22 17
10
9
Average number of outstanding shares, millions4) 212  211 211
211
210
PE, price/earnings ratio 29  111 44
24
23
Dividend per share, DKK3)4) 13.5  12.5 11.5
10.0
4.0
Pay-out ratio, %5) 77  82 77 78
38
Earnings per share (EPS), diluted4) 15  4 11
13
10
Free cash flow per share4) 11  14 11
13
11
           
1) Special items include costs of settlements and costs in connection with the lawsuits in the United States alleging injury resulting from the use of transvaginal surgical mesh products.
2) For the 2015/16, 2014/15 and 2013/14 financial years, this item is before Special items. After Special items, ROIC before tax is 80%/28%/51%, and ROIC after tax is 62%/21%/38%.
3) The figure shown for the 2015/16 financial year is the proposed dividend.             

4) The 2012/13 figure has been restated to reflect a 1-to-5 split of the company's A and B shares in the 2012/13 financial year. 

5) For the 2015/16, 2014/15 and 2013/14 financial years, this item is before Special items. After Special items, the pay-out ratio is 91%/294%/101%

The key ratios have been calculated and applied in accordance with “Recommendations & Financial Ratios 2015” issued by the Danish Society of Financial Analysts.
View desktop version